Michael Weiser

Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC.

Paramount Acquisition Corp. was incorporated in Delaware on June 1, 2005 as a blank check company with a objective to acquire an operating business. It is a newly organized Specified Purpose Acquisition Company. The purpose of its incorporation is effecting a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business in the healthcare industry.

Seward Sciences, Inc. operates as a development stage company. The company is headquartered in New York, NY.

Alacrity Biosciences, Inc. develops and markets pharmaceutical products, which are used in ophthalmology. The company was founded on November 9, 2006 and is headquartered in New York, NY.

Foresight Biotherapeutics, Inc. develops drugs and therapies for diseases of the eyes and ears. It offers FST-100 (topical ophthalmic drops combining povidone iodine and dexamethasone), a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye. The company was founded by Jason Stein and Michael Weiser on September 4, 2008 and is headquartered in New York, NY.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all.

American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC.

Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york.

Founded in 2006 by Michael Weiser and Jason Stein, Actin Biomed LLC is a venture capital firm located in New York City.

The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD.